David C Lye Selected Research

Creatinine

1/2016	The Significance of Prolonged and Saddleback Fever in Hospitalised Adult Dengue.
2/2014	Predictive value of proteinuria in adult dengue severity.
7/2008	Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David C Lye Research Topics

Disease

35	Infections 01/2024 - 07/2008
26	COVID-19 07/2024 - 01/2020
20	Dengue (Dengue Fever) 11/2020 - 05/2009
9	Hemorrhage 11/2020 - 05/2009
7	Fever (Fevers) 09/2020 - 11/2009
6	Bacteremia 11/2020 - 03/2013
6	Urinary Tract Infections (Urinary Tract Infection) 02/2019 - 05/2012
6	Severe Dengue 01/2018 - 01/2012
5	Sepsis (Septicemia) 08/2021 - 05/2014
4	Inflammation (Inflammations) 07/2024 - 11/2020
4	Communicable Diseases (Infectious Diseases) 03/2023 - 07/2008
4	Liver Abscess 01/2023 - 03/2013
4	Thrombocytopenia (Thrombopenia) 11/2020 - 05/2009
3	Disease Progression 03/2022 - 02/2014
3	Bacterial Infections (Bacterial Infection) 01/2022 - 06/2014
3	Pneumonia (Pneumonitis) 01/2022 - 04/2016
2	Breakthrough Infections 11/2023 - 01/2022
2	Gram-Negative Bacterial Infections 11/2020 - 01/2018
2	Diabetes Mellitus 01/2019 - 01/2018
2	Critical Illness (Critically Ill) 06/2017 - 04/2014
2	Melioidosis 01/2016 - 06/2013
2	Human Influenza (Influenza) 04/2010 - 12/2009
1	Vascular Diseases (Vascular Disease) 07/2024
1	Coinfection 05/2023
1	Reinfection 01/2023
1	Asymptomatic Infections 01/2023
1	Bacterial Pneumonia 01/2022
1	Acute Disease 01/2022
1	Dyspnea (Shortness of Breath) 01/2021
1	Vascular System Injuries 01/2021
1	Body Weight (Weight, Body) 11/2020
1	Conjunctivitis 11/2020
1	Acute Kidney Injury (Acute Renal Failure) 11/2020
1	Hypoxia (Hypoxemia) 09/2020

Drug/Important Bio-Agent (IBA)

17	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 11/2009
10	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2013
9	CytokinesIBA 07/2024 - 01/2020
7	VaccinesIBA 11/2023 - 01/2020
7	AntibodiesIBA 01/2023 - 03/2013
7	Carbapenems (Carbapenem Antibiotics)IBA 08/2021 - 01/2014
6	Immunoglobulin G (IgG)IBA 07/2024 - 01/2014
6	remdesivirIBA 02/2024 - 01/2021
6	Neutralizing AntibodiesIBA 01/2024 - 01/2020
5	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 08/2021 - 01/2014
4	EpitopesIBA 07/2024 - 01/2019
4	Peptides (Polypeptides)IBA 07/2024 - 01/2020
4	mRNA VaccinesIBA 01/2024 - 10/2021
4	AntigensIBA 01/2023 - 02/2014
4	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2023 - 01/2018
4	Immunoglobulin M (IgM)IBA 01/2021 - 01/2014
4	Vancomycin FDA LinkGeneric 11/2020 - 07/2008
3	baricitinibIBA 02/2024 - 01/2021
3	Antiviral Agents (Antivirals)IBA 02/2024 - 12/2009
3	Messenger RNA (mRNA)IBA 11/2023 - 10/2021
3	Alanine Transaminase (SGPT)IBA 03/2023 - 01/2012
3	BNT162 VaccineIBA 01/2023 - 10/2021
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2021
3	C-Reactive ProteinIBA 01/2022 - 01/2020
3	SARS-CoV-2 spike proteinIBA 01/2021 - 01/2020
3	Polymyxin B (Aerosporin)FDA LinkGeneric 11/2020 - 01/2014
3	CreatinineIBA 01/2016 - 07/2008
2	Immunologic Factors (Immunomodulators)IBA 02/2024 - 05/2023
2	Immunoglobulin A (IgA)IBA 11/2023 - 01/2021
2	sotrovimabIBA 01/2023 - 03/2022
2	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2023 - 01/2019
2	Oxygen (Dioxygen)IBA 01/2023 - 01/2021
2	Meropenem (Merrem)FDA LinkGeneric 08/2021 - 11/2018
2	RNA (Ribonucleic Acid)IBA 10/2020 - 01/2020
2	Viral RNAIBA 01/2020 - 12/2017
2	Ertapenem (Invanz)FDA Link 02/2017 - 09/2014
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2016 - 01/2012
2	Transaminases (Aminotransferases)IBA 01/2013 - 01/2012
1	Chemokine ReceptorsIBA 07/2024
1	AutoantibodiesIBA 07/2024
1	Alanine (L-Alanine)FDA Link 03/2023
1	TransferasesIBA 03/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2023
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2023
1	Viral Regulatory and Accessory ProteinsIBA 01/2023
1	COVID-19 VaccinesIBA 01/2023
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2023
1	ProcalcitoninIBA 01/2022
1	Staphylococcal Protein A (Protein A)IBA 01/2022
1	theasinensin AIBA 01/2022
1	ensovibepIBA 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	LuciferasesIBA 01/2021
1	LactamsIBA 11/2020
1	Immunoglobulins (Immunoglobulin)IBA 11/2020
1	Daptomycin FDA Link 11/2020
1	Peptide LibraryIBA 08/2020
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 08/2020

Therapy/Procedure

14	Therapeutics 12/2022 - 11/2009
6	Critical Care (Surgical Intensive Care) 11/2020 - 01/2013
5	Platelet Transfusion (Blood Platelet Transfusions) 11/2020 - 05/2009
5	Length of Stay 06/2017 - 03/2013
3	Artificial Respiration (Mechanical Ventilation) 01/2022 - 09/2020
1	Ambulatory Care (Outpatient Care) 01/2023
1	Noninvasive Ventilation 01/2021
1	Slit Lamp 11/2020